Covered recipient · General Payments record
ADAM C HARRISON
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$2,624.06
- Reported across 160 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $311.49 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $95.41 | 4 |
| Medtronic, Inc. | $57.17 | 3 |
| Astellas Pharma US Inc | $53.16 | 3 |
| Novo Nordisk AS | $34.38 | 2 |
| MEDICOMP INC | $30.90 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $21.08 | 1 |
| BOSTON SCIENTIFIC CORPORATION | $19.39 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $28.14 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103884739 | CMS |
| ABBVIE INC. | $27.85 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103884741 | CMS |
| ABBVIE INC. | $21.44 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103884743 | CMS |
| ABBVIE INC. | $17.98 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103884745 | CMS |
| Astellas Pharma US Inc | $15.70 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139304932 | CMS |
| Astellas Pharma US Inc | $18.11 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139370167 | CMS |
| Astellas Pharma US Inc | $19.35 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139426369 | CMS |
| Boston Scientific Corporation | $19.39 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092450014 | CMS |
| MEDICOMP INC | $30.90 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1067449394 | CMS |
| Medtronic, Inc. | $14.44 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119549613 | CMS |
| Medtronic, Inc. | $15.11 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119549615 | CMS |
| Medtronic, Inc. | $27.62 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119549617 | CMS |
| Novartis Pharmaceuticals Corporation | $21.08 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086905849 | CMS |
| Novo Nordisk Inc | $17.56 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097073922 | CMS |
| Novo Nordisk Inc | $16.82 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096685928 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.